INTRODUCTION

MATERIALS AND METHODS
ity period between the three patient groups. The E 2 level was significantly lower in group A compared to The study group was 49 women at risk of developing group B at the start of coasting. In group C the E 2 OHSS during ovarian stimulation for IVF or intracylevel (mean Ϯ SD) on day of hCG was 9800 Ϯ 3100 toplasmic sperm injection (ICSI). All patients received pg/ml, and 7200 Ϯ 2150 pg/ml after excluding the our long protocol using gonadotropin-releasing horfive cancelled patients. Both levels were significantly mone analogue (GnRH-a) and hMG (6) . The dose of higher than in groups A and B. The duration of coasting hMG (Pergonal; E.I.P. Co. Industries, Cairo, Egypt) was significantly shorter in group A. was 150 IU for patients below the age of 30 years, Injection of hCG was cancelled after a sudden 225 IU for patients between 30 and 35 years, and 300 decrease in E 2 level to below 1500 pg/ml in one patient IU for patients above the age of 35 years. Patients in group A and in four patients in group B. In group were defined as at risk of OHSS if over 20 follicles C, hCG injection was cancelled in five patients at high developed and E 2 exceeded 3000 pg/ml when the leadrisk of developing OHSS, and five patients developed ing follicle was 13 mm in diameter. They were allosevere OHSS, with no cases in groups A and B. Modercated on an alternate basis into two groups.
ate OHSS developed in one patient in group A, four In group A (n ϭ 25) the dose of hMG was reduced in group B and eight in group C. to 75 IU daily if the patient was receiving 150 IU or 225 IU of hMG, or to 150 IU if she was receiving 300 IU. Daily E 2 assay and ultrasound were done. DISCUSSION Menotropin injection ceased when the leading follicle was 16 mm in diameter. Coasting continued with daily
The use of coasting as a means of preventing OHSS monitoring until E 2 was 4000-5000 pg/ml, when was first proposed by Rabinovici et al. (9), who in 10,000 IU of hCG was given intramuscularly IM.
1987 reported withholding hMG for several days Transvaginal ultrasound-guided oocyte retrieval was before hCG administration in high-risk patients. performed 36 hr later.
Urman et al. (10) described 40 cycles in women with In group B (n ϭ 24), the dose of hMG was polycystic ovaries at risk for development of OHSS, unchanged. When the leading follicle reached 16 mm using coasting until E 2 level fell. A reasonable pregin diameter, complete coasting commenced. Other pronancy rate (PR) resulted with an OHSS rate of 2.5%. cedures were as group A. The coasting period was the Sher et al. (5, 11) also reported that coasting was effecnumber of days from final hMG injection to hCG tive in preventing OHSS. administration. A historical group C (n ϭ 32), in which Benadivia et al. (4) compared coasting and delaying E 2 was 3000 pg/ml with more than 20 follicles when hCG injection in high-risk patients with a control group the leading follicle was 13 mm in diameter, was used treated by cryopreservation of all embryos. There was as a comparison group. These patients continued the no significant difference in the fertilization rate (FR), same dose of hMG until the leading follicle reached miscarriage rate, delivery rate, and the incidence of 18-19 mm and hCG was given, unless the risk of OHSS between the two groups. The authors suggested OHSS was very high, when the cycle was cancelled.
that risk of cancellation cannot be completely elimiSemen preparation, oocyte handling, IVF, ICSI, and nated with coasting, but a high PR resulted without the embryo transfer were as previously described (7). need for repeated frozen-thawed cycles. Tortoriello et Luteal-phase support was in the form of 100 mg proal. (12) reported that coasting did not adversely affect gesterone IM (progesterone USP; STERIS, Phoenix, outcomes in a subset of highly responsive IVF patients. AZ). Clinical pregnancy was diagnosed by elevated We adopted the protocol of Sher et al. (11) for 1 serum ␤-hCG and ultrasound diagnosis of a gestational year, but although it was effective in the prevention sac with fetal echoes. The definitions of severe and of severe OHSS, in many patients the E 2 level fell moderate OHSS were based on the classification of suddenly to very low levels. This led to increased cycle Golan et al. (8) . Statistical analysis was done using a cancellation, poor oocyte quality, and low FR and PR one-way analysis of variance.
(unpublished data). We therefore planned a new coasting protocol in high-risk patients, starting when the leading follicle was 16 mm in diameter, irrespective RESULTS of the E 2 level, to minimize cycle cancellation. To test the hypothesis that a decrease in hMG dose would be Patient characteristics and results are shown in Table  I . There was no significant difference in age or infertilbeneficial, in group A the dose of hMG was reduced when the lead follicle diameter was 13 mm. In group the decline and is about to lose, if it has not already B, the dose was maintained until coasting. We gave lost, its capacity for producing high E 2 levels. hCG when E 2 was 4000-5000 pg/ml, rather than at These results support Sher's work (11) which states 3000 pg/ml as reported previously. Our study confirms that not only the E 2 level but also the size of the that the decline in E 2 levels occurs 2 to 3 days after leading follicle are important when coasting starts. If stopping hMG. The drop is unpredictable with levels prolonged coasting was initiated prior to 30% of the as low as 560 pg/ml (11) .
follicles having attained a mean diameter of 15 mm, With this modified coasting protocol, no cases of rapid decline in plasma E 2 concentration often folsevere OHSS occurred. Coasting duration was signifilowed and oocyte, follicular, and embryo quality were cantly shorter in group A. The periods of coasting are usually compromised. Our study suggests that reducing shorter than those reported by Rabinovici et al. 
days). Lowering the dose of hMG
In group C five patients developed severe OHSS, resulted in a significantly lower E 2 level in group A six patients developed moderate OHSS, and hCG on starting coasting compared to group B. This may administration was cancelled in five patients. None of account for the shorter coasting period in group A, the patients in groups A and B developed severe OHSS. which reduced the cancellation rate after a marked These numbers were too small for statistical analysis, drop of the E 2 level from four cancellations in group although the trend was for lower cancellation rates in B to only one cancellation in group A.
group A, less moderate OHSS with coasting, especially Based on outcomes in group C, giving hCG at an E 2 in group A, and the elimination of severe OHSS in level of 4000-5000 pg/ml in a cycle without coasting is groups A and B. associated with a risk of OHSS. However, giving hCG
In conclusion, this study illustrates the value of at the same E 2 level after coasting may not be associcoasting in the prevention of severe OHSS. When our ated with the same risk. The size of granulosa cell coasting protocol was preceded by a decreased hMG population available for luteinization following hCG dose, the duration of coasting and E 2 level before administration determines the incidence and severity coasting were significantly reduced. Our results also of OHSS (5) . Without coasting, the granulosa cell mass have financial implications, with a decrease in the is actively proliferating and will continue to produce amount of hMG used and lower monitoring costs due to higher levels of E 2 for a few days even in the absence of FSH. With coasting, the granulosa cell mass is on a shorter period of coasting. A prospective randomized fertilization for sibling oocytes in cases of unexplained infertilcontrolled trial to confirm these findings in a larger ity and borderline semen. J Assist Reprod Genet 1996;13:38-42 group of patients is needed. 
